ARTICLE | Clinical News
Atrix completes enrollment
July 19, 2000 7:00 AM UTC
ATRX said it completed enrollment earlier than expected in its double-blind, dose-ranging Phase II trial of Atrisone dapsone topical gel to treat moderate to severe acne. The company expects to begin ...